Not Yet RecruitingNot Applicable

High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers

France50 participantsStarted 2025-10-15

Plain-language summary

This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan. * Follow-up CT scan performed within 24 to 48 hours. Non-inclusion Criteria : * Absence of initial contrast-enhanced CT or follow-up CT. * Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH). Exclusion Criteria: * Patient deceased before the initial contrast-enhanced CT. * Major missing clinical data.

What they're measuring

Hematoma Expansion within 48 Hours: Increase of more than 6 mL or over 30% between the initial CT and the follow-up CT (PREDICT study criterion) and/or Occurrence of Death Within the First Month

Timeframe: 48 hours

Trial details

NCT IDNCT07172542

SponsorCentre Hospitalier de Gonesse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-15

View on ClinicalTrials.gov More Intracerebral Hemorrhage trials